Lizak, N. Et Al. 2020. Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis. JAMA NEUROLOGY , vol.77, no.11 , 1398-1407.

Lizak, N., Malpas, C. B., Sharmin, S., Havrdova, E. K., Horakova, D., Izquierdo, G., ... Eichau, S.(2020). Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis. JAMA NEUROLOGY , vol.77, no.11, 1398-1407.

Lizak, Nathaniel Et Al. "Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis," JAMA NEUROLOGY , vol.77, no.11, 1398-1407, 2020

Lizak, Nathaniel Et Al. "Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis." JAMA NEUROLOGY , vol.77, no.11, pp.1398-1407, 2020

Lizak, N. Et Al. (2020) . "Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis." JAMA NEUROLOGY , vol.77, no.11, pp.1398-1407.

@article{article, author={Nathaniel Lizak Et Al. }, title={Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis}, journal={JAMA NEUROLOGY}, year=2020, pages={1398-1407} }